AnalystRadar
MDGL Updated Aug 13, 2026

Madrigal Pharmaceuticals, Inc. (MDGL)

Analyst consensus, price target and coverage. 16 analysts, updated daily.

Consensus Strong Buy= Unchanged
Price 536.20 USD
Mean target 678.06 USD
Upside +26.5% target vs price
Market cap Large 12.4B

Analyst votes

How the ratings break down

17 ratings on record

Price targets

Where the estimates sit

How far apart analysts are on this name.

Low 543.00 Mean 678.06 High 962.00

share price 536.20 mean target 678.06. Analysts are spread 77% apart, and the share price sits below every target on record.

Most recent action

Last rating change

FirmWolfe Research
Date2026-08-04
ChangePeer Perform → Outperform

Size and liquidity

Key statistics

Market cap12.39B USD
Cap classLarge
Average volume363,782
Dollar volume per day195.1M
LiquidityHigh
Internal score80.8 / 100

Recommendation

How it moved, scan by scan

2 scans on record

ScanMoveConsensusScoreSBBuyHoldUndSell
2026-08-13 = Strong Buy 1.88 3 13 1 0 0
2026-08-11 · Strong Buy 1.88 3 13 1 0 0

Score is the analyst average on Yahoo's scale, where 1 is Strong Buy and 5 is Sell, so a falling number means the view improved. more positive, more negative, = unchanged.

History

Price target over time

2 daily points recorded

DatePriceTargetUpsideConsensus
2026-08-13 536.20 678.06 +26.5% Strong Buy
2026-08-11 526.47 678.06 +28.8% Strong Buy

Similar coverage

Comparable large-cap names

Closest upside among companies of the same size.

← All 1035 companies in the screener